Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$2.04 USD
+0.11 (5.70%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.05 | 0.00% |
Earnings Summary
For their last quarter, Coherus BioSciences (CHRS) reported earnings of -$0.62 per share, missing the Zacks Consensus Estimate of -$0.21 per share. This reflects a negative earnings surprise of 195.24%. Look out for CHRS's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.05 per share, reflecting a year-over-year increase of 93.33%.
Earnings History
Price & Consensus
Zacks News for CHRS
Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody
CHRS: What are Zacks experts saying now?
Zacks Private Portfolio Services